EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The new life of myectomy in the era of myosin inhibitors

Giovanni Quarta, Roberta Simona Cattaneo, Giacomo Bonacchi, Anna Rita Manca, Alfredo Giuseppe Cerillo, Attilio Iacovoni, Eduard Quintana, Samuele Pentiricci, Pierluigi Stefano, Michele Senni, Iacopo Olivotto

Progress in Cardiovascular Diseases · 2026

DOI: 10.1016/j.pcad.2026.01.004 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Progress in Cardiovascular Diseases, 2026. Verfasst von Giovanni Quarta und 10 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Department, ASST Papa Giovanni XXIII Hospital, Bergamo, Italy. Electronic address: gquarta@asst-pg23.it. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Septal Myectomy, Cardiac Myosins, Ventricular Outflow Obstruction, Left. Die Arbeit nennt 59 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The management of symptomatic obstructive hypertrophic cardiomyopathy remains a therapeutic clinical challenge. Surgical septal myectomy has long been established as the gold-standard intervention for patients with persistent symptoms despite optimal medical therapy, offering durable symptom relief with low perioperative risk in experienced centers. Recently, the introduction of cardiac myosin inhibitors, such as mavacamten and aficamten, has reshaped the treatment paradigm for obstructive hypertrophic cardiomyopathy. By selectively inhibiting cardiac myosin ATPase activity, these agents reduce hypercontractility and improve myocardial energetic efficiency. Randomized, placebo-controlled trials such as EXPLORER-HCM and SEQUOIA-HCM have demonstrated the efficacy of cardiac myosin inhibitors in reducing left ventricular outflow tract gradients, alleviating symptoms, and enhancing functional capacity in patients with obstructive hypertrophic cardiomyopathy. The growing clinical use of cardiac myosin inhibitors raises critical questions regarding their role relative to surgical intervention. While cardiac myosin inhibitors offer an effective and less invasive alternative for many patients, they do not fully replace surgical myectomy across all clinical settings. This review articles explores the evolving therapeutic landscape of obstructive hypertrophic cardiomyopathy, focusing on the comparative advantages and limitations of cardiac myosin inhibitors and surgical myectomy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiomyopathy, HypertrophicSeptal MyectomyCardiac MyosinsVentricular Outflow Obstruction, LeftHumansTreatment OutcomeAnimalsMyocardial Contraction

Stichwörter der Autor:innen

Cardiac myosin inhibitorsMyectomyObstructive hypertrophic cardiomyopathy

Substanzen

Cardiac Myosins

Autor:innen und Institutionen

  • Cardiovascular Department, ASST Papa Giovanni XXIII Hospital, Bergamo, Italy. Electronic address: gquarta@asst-pg23.it.
  • Cardiovascular Department, ASST Papa Giovanni XXIII Hospital, Bergamo, Italy.
  • Cardiomyopathy Unit, Careggi University Hospital, Florence, Italy.
  • Cardiac Surgery Unit, AOU Careggi, Firenze, Italy.
  • Department of Cardiovascular Surgery, Hospital Clinic de Barcelona, University of Barcelona, Barcelona, Spain.
  • Cardiac Surgery Unit, ASST Papa Giovanni XXIII Hospital, Bergamo, Italy.

Zitieren

APA

Quarta, G., Cattaneo, R. S., Bonacchi, G., Manca, A. R., Cerillo, A. G., Iacovoni, A., Quintana, E., Pentiricci, S., Stefano, P., Senni, M., & Olivotto, I. (2026). The new life of myectomy in the era of myosin inhibitors. Progress in Cardiovascular Diseases. https://doi.org/10.1016/j.pcad.2026.01.004

Vancouver

Quarta G, Cattaneo RS, Bonacchi G, Manca AR, Cerillo AG, Iacovoni A, et al. The new life of myectomy in the era of myosin inhibitors. Progress in Cardiovascular Diseases. 2026. doi:10.1016/j.pcad.2026.01.004

BibTeX
@article{Quarta2026,
  author = {Quarta, Giovanni and Cattaneo, Roberta Simona and Bonacchi, Giacomo and Manca, Anna Rita and Cerillo, Alfredo Giuseppe and Iacovoni, Attilio and Quintana, Eduard and Pentiricci, Samuele and Stefano, Pierluigi and Senni, Michele and Olivotto, Iacopo},
  title = {The new life of myectomy in the era of myosin inhibitors},
  journal = {Progress in Cardiovascular Diseases},
  year = {2026},
  doi = {10.1016/j.pcad.2026.01.004}
}
Kostenlos starten →